Chamoso-Sanchez D, Panini M, Caroli C, Marani M, Corsi L, Ruperez F
Sci Rep. 2025; 15(1):2238.
PMID: 39824876
PMC: 11742047.
DOI: 10.1038/s41598-025-86044-5.
Secades J, Gareri P
Rev Neurol. 2022; 75(s05):S1-S89.
PMID: 36544369
PMC: 10548480.
DOI: 10.33588/rn.75s05.2022311.
Li W, Lee K, Chen L, You B, Lee H
Front Pharmacol. 2022; 13:888863.
PMID: 35784738
PMC: 9243229.
DOI: 10.3389/fphar.2022.888863.
de Dios-Perez I, Gonzalez-Garcinuno A, Martin Del Valle E
Molecules. 2022; 27(9).
PMID: 35566086
PMC: 9105759.
DOI: 10.3390/molecules27092735.
Zheng X, Xin Y, Peng Y, Shan J, Zhang N, Wu D
Sci China Life Sci. 2020; 64(9):1502-1521.
PMID: 33165813
DOI: 10.1007/s11427-020-1834-9.
Evaluation of the antitumor effects of PP242 in a colon cancer xenograft mouse model using comprehensive metabolomics and lipidomics.
Rashid M, Lee H, Jung B
Sci Rep. 2020; 10(1):17523.
PMID: 33067464
PMC: 7568555.
DOI: 10.1038/s41598-020-73721-w.
Aberrant activation of super enhancer and choline metabolism drive antiandrogen therapy resistance in prostate cancer.
Wen S, He Y, Wang L, Zhang J, Quan C, Niu Y
Oncogene. 2020; 39(42):6556-6571.
PMID: 32917955
DOI: 10.1038/s41388-020-01456-z.
CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor.
Phyu S, Tseng C, Smith T
MAGMA. 2018; 32(2):227-235.
PMID: 30446846
PMC: 6424927.
DOI: 10.1007/s10334-018-0719-3.
Response of Cisplatin Resistant Skov-3 Cells to [Pt(-Acac)(γ-Acac)(DMS)] Treatment Revealed by a Metabolomic ¹H-NMR Study.
Castro F, Benedetti M, Antonaci G, Del Coco L, De Pascali S, Muscella A
Molecules. 2018; 23(9).
PMID: 30205612
PMC: 6225129.
DOI: 10.3390/molecules23092301.
The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model.
Papaevangelou E, Almeida G, Box C, deSouza N, Chung Y
Int J Cancer. 2018; 143(4):992-1002.
PMID: 29569717
PMC: 6055739.
DOI: 10.1002/ijc.31392.
Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice.
Sonzogni-Desautels K, Renteria A, Camargo F, Di Lenardo T, Mikhail A, Arrowood M
Front Microbiol. 2015; 6:973.
PMID: 26441906
PMC: 4585137.
DOI: 10.3389/fmicb.2015.00973.
A mechanism for suppression of the CDP-choline pathway during apoptosis.
Morton C, Aitchison A, Gehrig K, Ridgway N
J Lipid Res. 2013; 54(12):3373-84.
PMID: 24136823
PMC: 3826684.
DOI: 10.1194/jlr.M041434.
Metabolomic Analysis of the Effect of Postnatal Hypoxia on the Retina in a Newly Born Piglet Model.
Solberg R, Escobar J, Arduini A, Torres-Cuevas I, Lahoz A, Sastre J
PLoS One. 2013; 8(6):e66540.
PMID: 23823578
PMC: 3688918.
DOI: 10.1371/journal.pone.0066540.
Effects of narrow band UVB (311 nm) irradiation on epidermal cells.
Reich A, Medrek K
Int J Mol Sci. 2013; 14(4):8456-66.
PMID: 23594996
PMC: 3645754.
DOI: 10.3390/ijms14048456.
ras-Induced up-regulation of CTP:phosphocholine cytidylyltransferase α contributes to malignant transformation of intestinal epithelial cells.
Arsenault D, Yoo B, Rosen K, Ridgway N
J Biol Chem. 2012; 288(1):633-43.
PMID: 23155050
PMC: 3537062.
DOI: 10.1074/jbc.M112.347682.
Phosphatidylcholine and the CDP-choline cycle.
Fagone P, Jackowski S
Biochim Biophys Acta. 2012; 1831(3):523-32.
PMID: 23010477
PMC: 3562404.
DOI: 10.1016/j.bbalip.2012.09.009.
Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation.
Boren J, Brindle K
Cell Death Differ. 2012; 19(9):1561-70.
PMID: 22460322
PMC: 3422477.
DOI: 10.1038/cdd.2012.34.
Metabolomics in the fields of oncology: a review of recent research.
Ma Y, Zhang P, Yang Y, Wang F, Qin H
Mol Biol Rep. 2012; 39(7):7505-11.
PMID: 22350159
DOI: 10.1007/s11033-012-1584-1.
Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.
Moestue S, Engebraaten O, Gribbestad I
Mol Oncol. 2011; 5(3):224-41.
PMID: 21536506
PMC: 5528296.
DOI: 10.1016/j.molonc.2011.04.001.
Molecular mechanisms involved in farnesol-induced apoptosis.
Joo J, Jetten A
Cancer Lett. 2009; 287(2):123-35.
PMID: 19520495
PMC: 2815016.
DOI: 10.1016/j.canlet.2009.05.015.